Indapamide Lp Viatris

Indapamide, the active ingredient in Indapamide Lp Viatris, is a thiazide‑like diuretic presented as an oral tablet for systemic use. It lowers elevated blood pressure and reduces fluid accumulation in patients with hypertension, heart‑failure‑related edema, or renal‑disease‑related edema, and is commonly prescribed when lifestyle measures alone are insufficient.

GNH USA supplies Indapamide Lp Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable delivery and regulatory compliance across multiple regions.

Indapamide is indicated for conditions involving excess fluid retention or elevated arterial pressure. - Hypertension: reduces systolic and diastolic blood pressure, helping to achieve target levels. - Edema associated with heart failure: promotes diuresis to decrease fluid overload and improve symptoms. - Edema associated with renal disease: facilitates fluid removal, aiding in the management of renal‑related swelling.

Indapamide may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Increased urination: may experience a noticeable rise in frequency of voiding, especially during the first days of therapy. - Low potassium (hypokalemia): can cause muscle weakness, cramps, or fatigue. - Dizziness or light‑headedness: often occurs when standing up quickly due to reduced blood pressure. - Elevated blood glucose: may modestly raise glucose levels, requiring monitoring in diabetic patients.

Serious or Rare Side Effects: - Severe electrolyte imbalance: significant hyponatremia, hyperuricemia, or hypokalemia that may need medical intervention. - Acute kidney injury: sudden increase in serum creatinine or reduced urine output indicating renal dysfunction. - Allergic reactions: rash, pruritus, swelling, or rare anaphylactic responses requiring immediate care.

When prescribing Indapamide, clinicians should consider several precautionary measures to ensure safe use. - Monitor electrolytes: regularly check serum potassium, sodium, and uric acid levels. - Assess renal function: evaluate creatinine and glomerular filtration rate before and during treatment. - Evaluate blood pressure: avoid excessive hypotension, especially in volume‑depleted patients. - Caution in diabetes: monitor glucose as the drug may raise blood sugar. - Avoid use in severe hepatic impairment: limited data suggest increased risk of toxicity. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Indapamide can interact with other medicines, altering its diuretic effect or electrolyte balance.

Major Interactions (Avoid): - Lithium: concurrent use can raise lithium levels, risking toxicity. - NSAIDs (e.g., ibuprofen, naproxen): may reduce diuretic efficacy and worsen renal function. - ACE inhibitors or ARBs: combined therapy can precipitate severe hypotension or hyperkalemia.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: diuretic‑induced hyperglycemia may require dose adjustment. - Antihypertensives (beta‑blockers, calcium channel blockers): additive blood‑pressure‑lowering effect may cause excessive hypotension. - Digoxin: electrolyte shifts, especially low potassium, can increase digoxin toxicity risk.